Matches in Nanopublications for { ?s ?p "[Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 14 of
14
with 100 items per page.
- NP692001.RAqego_xLHzpbsewvLpHWO_bppEWJeHomNXZQAS2Sz-dI130_assertion description "[Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP692001.RAqego_xLHzpbsewvLpHWO_bppEWJeHomNXZQAS2Sz-dI130_provenance.
- NP595394.RAuTnVPvDzGuu9hPmAVPV2gl7lVq-G_1nLZupjJ_7MTo0130_assertion description "[Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP595394.RAuTnVPvDzGuu9hPmAVPV2gl7lVq-G_1nLZupjJ_7MTo0130_provenance.
- assertion description "[Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP271078.RAY_vHPNrtYdsLw6EoDwcZcYJscuNzputPAo9fDN9lE0s130_assertion description "[Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP271078.RAY_vHPNrtYdsLw6EoDwcZcYJscuNzputPAo9fDN9lE0s130_provenance.
- assertion description "[Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP824244.RAdereYFmonmM1AFqsvqjsPRyJzF2KpbjFMjtV17sAwU4130_assertion description "[Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP824244.RAdereYFmonmM1AFqsvqjsPRyJzF2KpbjFMjtV17sAwU4130_provenance.
- NP796352.RAMc9tAIFnSr4uFmPFNC609WwL7QS4a2rBD7Nv8b_V9g8130_assertion description "[Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP796352.RAMc9tAIFnSr4uFmPFNC609WwL7QS4a2rBD7Nv8b_V9g8130_provenance.
- NP225231.RA2_Jo2RRLgizePbw6MFGYKiO5L0_p6LUldgut0JBB70w130_assertion description "[Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP225231.RA2_Jo2RRLgizePbw6MFGYKiO5L0_p6LUldgut0JBB70w130_provenance.
- NP273327.RAxCWN8N261eVLQBfPInfdeXyL4V2-PPckfQqdehFuQEA130_assertion description "[Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP273327.RAxCWN8N261eVLQBfPInfdeXyL4V2-PPckfQqdehFuQEA130_provenance.
- NP824239.RA1Xo_Da_rs66jh9cCg8RcafCtXpTAaL2lhW85mAaKh24130_assertion description "[Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP824239.RA1Xo_Da_rs66jh9cCg8RcafCtXpTAaL2lhW85mAaKh24130_provenance.
- NP824243.RA3zDBF98KL1zPoW7p31Tjwfz2RHQj8x5MSiqk3_Y0fHU130_assertion description "[Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP824243.RA3zDBF98KL1zPoW7p31Tjwfz2RHQj8x5MSiqk3_Y0fHU130_provenance.
- NP180729.RA014wgOTUQZETB-6mVjWIRTYS2xgLoNBCRS2Xs2iUU-Q130_assertion description "[Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP180729.RA014wgOTUQZETB-6mVjWIRTYS2xgLoNBCRS2Xs2iUU-Q130_provenance.